Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

General strategies to set quality specifications for reliability performance characteristics.

C G Fraser1

  • 1Directorate of Biochemical Medicine, Ninewells Hospital and Medical School, Dundee, Scotland.

Scandinavian Journal of Clinical and Laboratory Investigation
|February 10, 2000
PubMed
Summary

This study explores how to set quality specifications in laboratory medicine. It suggests that these specifications should be based on biological variation components. The authors analyzed how errors affect clinical decisions and found that biological variation best informs specification setting. They propose that precision, bias, and allowable differences should align with these components. The study does not introduce new methods but synthesizes existing ones. It highlights the need for standardized guidelines. The findings suggest a framework for improving clinical decision-making accuracy. The authors do not claim this is the only valid approach but propose it as a reliable basis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scottish Bowel Screening Programme colonoscopy quality - scope for improvement?

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018
Same author

Participation in bowel screening among men attending abdominal aortic aneurysm screening.

The British journal of surgery·2018
Same author

Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Same author

Low faecal haemoglobin concentration potentially rules out significant colorectal disease.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2012
Same author

The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study.

British journal of cancer·2012
Same author

Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a contraindication to continued screening.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2011

Area of Science:

  • Clinical laboratory standards
  • Biological variation analysis
  • Quality assurance in medicine

Background:

Establishing quality specifications in laboratory medicine remains a challenge. Prior research has shown that various strategies exist for setting these specifications. However, uncertainty persists regarding the most effective approach. This gap motivated researchers to explore methods grounded in biological variation components. It was already known that error impacts clinical decisions. Yet, no prior work had resolved how best to derive specifications from biological variation. The need for a systematic approach became evident. This paper aims to address that need. It builds on prior knowledge of error effects and clinical decision-making.

Purpose Of The Study:

The study's aim is to evaluate strategies for setting quality specifications in laboratory medicine. It focuses on how biological variation components influence these specifications. The specific problem is the lack of a unified framework for deriving specifications. Researchers propose that precision, bias, and allowable differences should be based on biological variation. This approach could improve clinical decision-making accuracy. The motivation stems from the need for standardized, evidence-based guidelines. The study does not propose new methods but synthesizes existing ones. It highlights the importance of aligning specifications with biological variation.

Keywords:
laboratory medicine standardsbiological variation analysisclinical decision accuracyquality assurance methods

Frequently Asked Questions

The authors propose that precision and bias specifications should align with biological variation components.

Allowable differences depend on biological variation components, according to the study.

Biological variation components best inform specifications, as shown in the analysis.

Fixed limits derive from biological variation components, as the study suggests.

Related Experiment Videos

Main Methods:

The researchers reviewed existing literature on quality specifications in laboratory medicine. They analyzed the impact of analytical errors on clinical decisions. The approach involved examining biological variation components. They considered precision, bias, and allowable differences between methods. The study did not use new data but synthesized prior findings. They evaluated how biological variation influences specification setting. The analysis included fixed limits for external quality assessment. The goal was to identify the most effective derivation methods.

Main Results:

The strongest finding is that biological variation components best inform quality specifications. Precision and bias specifications should align with biological variation. Allowable differences between methods also depend on these components. Fixed limits for external quality assessment derive from biological variation. The study found no superior alternative to this approach. No prior work had demonstrated this relationship clearly. The results suggest a systematic framework for specification setting. These findings are consistent with clinical decision-making requirements.

Conclusions:

The authors propose that quality specifications should derive from biological variation components. They suggest that this approach improves clinical decision-making accuracy. No essentiality is assigned to any single component. The synthesis implies a need for standardized guidelines. The findings do not propose new methods but reinforce existing ones. They highlight the importance of aligning specifications with biological variation. The authors do not claim this is the only valid approach. Their conclusion is that biological variation provides a reliable basis for specification setting.

Aligning specifications with biological variation reduces error impact on decisions.

The authors propose that biological variation provides a reliable basis for specification setting.